1. High plasma levels of soluble LOX-1 portends poor survival in acute coronary syndromes beyond GRACE 2.0: a multicentre prospective cohort study. (14th October 2021) Authors: Kraler, S; Obeid, S; Liberale, L; Von Eckardstein, A; Wenzl, F A; Paneni, F; Matter, C; Muller, O; Raeber, L; Mach, F; Akhmedov, A; Luescher, T F Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Limited sex-specific performance of the GRACE 2.0 score to predict reinfarction or death in NSTEMI patients during pro-inflammatory states. (14th October 2021) Authors: Kraler, S; Wenzl, F; Obeid, S; Aghlmandi, S; Paneni, F; Matter, C; Muller, O; Raeber, L; Von Eckardstein, A; Mach, F; Luescher, T F Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Novel plasma biomarkers in arrhythmogenic cardiomyopathy: the role of ST2 and GDF-15 in predicting biventricular involvement. (25th November 2020) Authors: Akdis, D; Chen, L; Saguner, A.M; Zhang, N; Gawinecka, J; Saleh, L; Von Eckardstein, A; Ren, J; Matter, C; Hu, Z; Ruschitzka, F; Chen, X; Brunckhorst, C; Song, J; Duru, F Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Quality matters: low-density lipoprotein electronegativity but not quantity determines mortality risk in acute coronary syndromes. (3rd October 2022) Authors: Kraler, S; Wenzl, F A; Shen, M Y; Von Eckardstein, A; Raeber, L; Mach, F; Nanchen, D; Matter, C; Gencer, B; Camici, G G; Chen, C H; Akhmedov, A; Luescher, T F Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Remnant cholesterol contributes to residual lipid risk after acute coronary syndromes. (3rd October 2022) Authors: Wenzl, F; Kraler, S; Raeber, L; Von Eckardstein, A; Matter, C; Gencer, B; Nanchen, D; Rodondi, N; Mach, F; Luescher, T Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sex-specific differences in total ischemic time coincide with similar cardiovascular outcome in patients with acute coronary syndrome: a Swiss multicentre cohort study. (14th October 2021) Authors: Kraler, S; Obeid, S; Aghlmandi, S; Wenzl, F; Paneni, F; Matter, C; Muller, O; Raeber, L; Mach, F; Luescher, T F Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes. (25th November 2020) Authors: Davies, A; Li, X; Obeid, S; Roffi, M; Klingenberg, R; Mach, F; Raber, L; Windecker, S; Templin, C; Muller, O; Nanchen, D; Matter, C; Wang, Z; Hazen, S; Luescher, T Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗